Abeona Therapeutics Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 8.7M | 5.4M | 0 | 400K | 0 | 0 | 0 | 0 |
| Cost of Goods Sold | 3.6M | 2.8M | 488K | 100K | 0 | 776K | 0 | 0 |
| Gross Profit | 5.2M | 2.6M | -488K | 300K | 0 | -776K | 0 | 0 |
| R&D Expenses | 9.6M | 6.7M | 4.2M | 5.9M | 9.9M | 9.0M | 8.9M | 9.2M |
| Operating Expenses | 28.2M | 25.5M | 23.5M | 23.1M | 19.7M | 15.9M | 15.3M | 17.9M |
| Operating Income | -23.0M | -22.9M | -24.0M | -22.8M | -19.7M | -16.7M | -15.3M | -17.9M |
| Other Income / Gains | 6.0M | 2.2M | 3.7M | 147.1M | 7.7M | 7.4M | -14.9M | 25.3M |
| Net Income | -17.1M | -20.5M | -5.2M | 108.8M | -12.0M | -9.3M | -30.3M | 7.4M |
| EPS (Diluted) | -0.30 | -0.39 | -0.095 | 2.07 | -0.24 | -0.23 | -0.63 | 0.19 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.591 | 0.477 | 0 | 0.75 | 0 | 0 | 0 | 0 |
| General And Administrative Expenses | 0 | 18.8M | 19.3M | 17.1M | 9.8M | 0 | 6.4M | 8.6M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 18.6M | 18.8M | 19.3M | 17.1M | 9.8M | 6.9M | 6.4M | 8.6M |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 31.8M | 28.3M | 24.0M | 23.2M | 19.7M | 16.7M | 15.3M | 17.9M |
| Interest Income | 1.4M | 1.5M | 1.7M | 1.0M | 1.3M | 1.0M | 1.2M | 1.2M |
| Interest Expense | 830K | 884K | 901K | 957K | 998K | 1.1M | 1.1M | 1.1M |
| Depreciation And Amortization | 869K | 1.1M | 888K | 768K | 815K | 776K | 722K | 685K |
| Ebitda | -15.4M | -18.7M | -18.6M | 126.1M | -10.2M | -7.4M | -28.4M | 9.2M |
| Ebitdaratio | -1.763 | -3.45 | 0 | 315.175 | 0 | 0 | 0 | 0 |
| Operating Income Ratio | -2.641 | -4.227 | 0 | -56.98 | 0 | 0 | 0 | 0 |
| Income Before Tax | -17.1M | -20.7M | -20.4M | 124.3M | -12.0M | -9.3M | -30.3M | 7.4M |
| Income Before Tax Ratio | -1.958 | -3.815 | 0 | 310.863 | 0 | 0 | 0 | 0 |
| Income Tax Expense | 2K | -215K | -15.2M | 15.5M | 0 | 0 | 0 | 0 |
| Net Income Ratio | -1.958 | -3.775 | 0 | 272.083 | 0 | 0 | 0 | 0 |
| Epsdiluted | -0.30 | -0.36 | -0.095 | 1.71 | -0.24 | -0.23 | -0.63 | 0.14 |
| Weighted Average Shs Out | 56.6M | 53.0M | 54.2M | 52.5M | 49.8M | 41.0M | 48.1M | 40.0M |
| Weighted Average Shs Out Dil | 56.6M | 66.1M | 54.2M | 66.6M | 49.8M | 41.0M | 48.1M | 51.2M |